Craniotomy: Clinical Trials

9 trials of Craniotomy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 not yet recruiting, 1 recruiting. 9 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 19Completed 7, Not yet recruiting 1, Recruiting 1
Phase 21Completed 1

Follow Craniotomy: new trials by email Literature Review of Craniotomy trials Research Report on Craniotomy

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG
SBK2-ICG, Craniotomy (Standard of Care) - Malignant Brain Tumors, Glioma
Phase 1Not yet recruitingTiffany Hodges122026-11-022026-10-06
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
Allogeneic Adipose-derived Mesenchymal Stem Cells, Biospecimen Collection, Craniotomy - Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4
Phase 1RecruitingMayo Clinic202023-06-162026-04-02
Enhancing Optune Therapy With Targeted Craniectomy
Optune, Craniectomy - Glioblastoma
Phase 1CompletedAarhus University Hospital152016-10-012019-11-27
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion chambers in the rectus sheath with IGF-1R/AS ODN within 24 hours of craniotomy, implanted for 48 hours. - Malignant Glioma, Neoplasms
Phase 1Completeddavid andrews332015-09-012025-05-07
Preoperative Chemoradiation for Glioblastoma
Temozolomide, partial brain irradiation, stereotactic biopsy of brain tumor - Glioblastoma
Phase 1CompletedTampa General Hospital12014-11-012015-11-10
Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
carboplatin, Surgery - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma
Phase 1CompletedJames Elder102012-06-112018-07-02
DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
DNX-2401, Tumor Removal - Brain Cancer, Central Nervous System Diseases
Phase 1CompletedDNAtrix, Inc.372009-02-012018-07-16
Oligodendrocyte Progenitor Cell Culture From Human Brain
Oligodendrocyte progenitor cell culture/craniotomy - Demyelinating Diseases
Phase 1CompletedDepartment of Medical Services Ministry of Public Health of Thailand52007-12-012020-10-19
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
HSPPC-96, Standard Surgical Resection - Brain and Central Nervous System Tumors
Phase 1 / Phase 2CompletedUniversity of California, San Francisco962005-11-182021-05-13

Conditions studied

Brain Neoplasms (4)  ·  Glioblastoma (4)  ·  Glioma (4)  ·  Astrocytoma (2)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Demyelinating Diseases (1)  ·  Neoplasms (1)  ·  Oligodendroglioma (1)

Sponsors

Aarhus University Hospital (1)  ·  DNAtrix, Inc. (1)  ·  Department of Medical Services Ministry of Public Health of Thailand (1)  ·  James Elder (1)  ·  Mayo Clinic (1)  ·  Tampa General Hospital (1)  ·  Tiffany Hodges (1)  ·  University of California, San Francisco (1)  ·  david andrews (1)

Countries

United States (7)  ·  Denmark (1)  ·  Thailand (1)

Top investigators

Alfredo Quinones-Hinojosa, MD (1)  ·  Anders R Korshoej, MD (1)  ·  Frederick F. Lang, MD, BS (1)  ·  James Elder (1)  ·  Jennifer Clarke, MD (1)  ·  Kevin Judy, MD (1)  ·  Lawrence Berk, MD, PhD (1)  ·  Subsai Kongsaengdao, M.D. (1)  ·  Tiffany Hodges, MD (1)

Results publications

PMID 24335700, PMID 29432077, PMID 30641498, PMID 33500356, PMID 38311852

NIH funding

P50CA097257 (1), R01CA164714 (1)